Bloomberg News

Celesio Buys 60% of Brazilian Specialty Pharma Company Oncoprod

October 10, 2011

Oct. 10 (Bloomberg) -- Celesio AG bought 60 percent of Brazil’s Oncoprod Group, a specialty pharmaceutical distributor with a focus on highly complex medicines, the company said in an e-mailed statement today.

To contact the editor responsible for this story: Mariajose Vera at mvera1@bloomberg.net


We Almost Lost the Nasdaq
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus